Deals
Deals dated after 30 September 2026 are still being collected.
Columns
7 of 7 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2026 | Robinhood Ventures Fund II | – | – | IPO | Legal adviser to the issuer | Listed | 200.0 | Investment Vehicles | Goldman Sachs (lead manager)Citi (lead manager)J.P. Morgan (lead manager)UBS (lead manager)Wells Fargo Securities (lead manager)Davis Polk (issuer)Sullivan & Cromwell (lead manager) | Robinhood Ventures Fund II IPO |
| Jun 2026 | Standard BioTools | – | – | Merger | Legal adviser to Standard BioTools (acquirer) | Pending | 460.0 | Biotech+2 | Centerview Partners (buy-side)Freshfields (buy-side)UBS (buy-side)Wedbush Securities (sell-side)Fenwick & West (sell-side) | Treeline Biosciences and Standard BioTools merger |
| Apr 2026 | Kashiv BioSciences | – | Amneal Pharmaceuticals | Acquisition | Legal adviser to Committee of Independent Directors of the Board of Directors (acquirer) | Completed | 375.0 | Biotech+2 | Goldman Sachs (buy-side)Simpson Thacher & Bartlett (buy-side)J.P. Morgan (sell-side)Holland & Knight (sell-side)Boston Consulting Group (buy-side) | Amneal Pharmaceuticals acquisition of Kashiv BioSciences |
| Mar 2026 | Robinhood Ventures Fund I | – | – | IPO | Legal adviser to the issuer | Listed | 315.4 | Investment Vehicles | Goldman Sachs (lead manager)Davis Polk (issuer)Sullivan & Cromwell (lead manager) | Robinhood Ventures Fund I IPO |
| Feb 2026 | KORE Group Holdings | – | Searchlight Capital Partners, L.P. | Acquisition | Legal adviser to Special Committee (target) | Completed | 726.0 | Telecom+2 | Rothschild & Co (sell-side)Troutman Pepper Locke (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side)Kirkland & Ellis (buy-side)TD Securities (buy-side) | Searchlight Capital Partners, L.P. acquisition of KORE Group Holdings |
| Feb 2026 | Kennedy-Wilson Holdings | – | William McMorrow and Fairfax consortium | Acquisition | Legal adviser to Special Committee of Kennedy Wilson (target) | Pending | – | Real Estate+1 | Moelis & Company (sell-side)Cravath, Swaine & Moore (sell-side)BofA Securities (buy-side)J.P. Morgan (buy-side)Debevoise & Plimpton (buy-side)A&O Shearman (buy-side)Latham & Watkins (sell-side)Ropes & Gray (sell-side)Sidley Austin | William McMorrow and Fairfax consortium acquisition of Kennedy-Wilson Holdings |
| Dec 2025 | Freenome Holdings | – | Perceptive Capital Solutions Corp | Merger | Legal adviser to Freenome Strategic Transaction Committee (target) | Completed | 725.0 | Diagnostics+2 | Jefferies (buy-side)Leerink Partners (buy-side)TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Cooley (buy-side)Greenberg Traurig (sell-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)H.C. Wainwright & Co. (sell-side) | Perceptive Capital Solutions Corp and Freenome Holdings merger |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
- J.P. Morgan
2 dealsCompare - Wachtell, Lipton, Rosen & Katz
1 dealCompare - Kirkland & Ellis
1 dealCompare - TD Securities1 dealCompare
- Holland & Knight1 dealCompare
- Jefferies
1 dealCompare - Leerink Partners1 dealCompare
- Cooley1 dealCompare
Firms advising the other side of the same deals.